NLRP3 and early-onset autosomal dominant Alzheimer disease: Emerging studies now focus heavily on understanding the mechanisms underlying NLRP3 activation in microglia in inflammation associated with neuropathology ranging from neurodegenerative diseases such as Alzheimer’s disease to psychiatric illnesses.